Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

News > All

Total search results: 17246 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 171 172 173  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA. 2020-08-14
Calliditas Therapeutics AB. (8/13/20). "Press Release: Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA". 2020-08-13
Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo. 2020-08-13
Novo Holdings A/S. (8/12/20). "Press Release: Novo Ventures Portfolio Company F2G Closes US$60.8 Million Financing". Copenhagen. 2020-08-12
Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA. 2020-08-12
Atriva Therapeutics GmbH. (8/11/20). "Press Release: Atriva Announces Closing of € 8.6 Million ($ 10.2 Million) Oversubscribed Convertible Loan". Tübingen. 2020-08-11
Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin. 2020-08-11
Saillant Therapeutics B.V.. (8/11/20). "Press Release: Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication". Nijmegen. 2020-08-11
Dyne Therapeutics Inc.. (8/10/20). "Press Release: Dyne Therapeutics Announces $115 Million Financing to Advance Pipeline of Modern Oligonucleotide Therapeutics for Serious Muscle Diseases". Waltham, MA. 2020-08-10
Immunic, Inc.. (8/10/20). "Press Release: Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters’ Option to Purchase Additional Shares". New York, NY. 2020-08-10
CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen. 2020-08-10
NBE Therapeutics AG. (8/10/20). "Press Release: NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors". Basel. 2020-08-10
Oasmia Pharmaceutical AB. (8/10/20). "Press Release: Oasmia Pharmaceutical Appoints Peter Selin as Chief Business Officer". Uppsala. 2020-08-10
Inveox GmbH. (8/10/20). "Press Release: Roche Diagnostics Germany and Inveox Jointly Drive Digital Solutions in Histopathology". Mannheim & Garching. 2020-08-10
Merck KGaA. (8/6/20). "Press Release: Leadership Change within Group Communications at Merck". Darmstadt. 2020-08-06
T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin. 2020-08-06
Histologix Ltd.. (8/5/20). "Press Release: Histologix Appoints New Managing Director to Take Company through Ambitious Growth Plans". 2020-08-05
GentiBio, Inc.. (8/5/20). "Press Release: GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Infl 2020-08-05
Immunic, Inc.. (8/5/20). "Press Release: Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock". New York, NY. 2020-08-05
H. Lundbeck A/S. (8/5/20). "Press Release: Lundbeck Discontinues Phase II Proof of Concept Study of Lu AF11167 in Patients with Negative Symptoms of Schizophrenia". Valby. 2020-08-05
Evotec SE. (8/5/20). "Press Release: Evotec and Secarna Pharmaceuticals Form Strategic Partnership in the Field of Antisense Therapy". Hamburg & Marburg. 2020-08-05
Versant Ventures. (8/5/20). "Press Release: Versant Ventures Launches Matterhorn Biosciences". Basel. 2020-08-05
Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. 2020-08-05
AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. 2020-08-05
Thermo Fisher Scientific Inc.. (8/4/20). "Press Release: Thermo Fisher Scientific Confirms Offer to Acquire Qiagen Shares Expires on August 10". Waltham, MA. 2020-08-04
CureVac AG. (8/4/20). "Press Release: CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and Dr. Igor Splawski as Chief Scientific Officer". Tübingen. 2020-08-04
Redx Pharma plc. (8/4/20). "Press Release: Redx Signs Out Licensing Agreement with AstraZeneca". Alderley Park. 2020-08-04
Spindiag GmbH. (8/4/20). "Press Release: Spindiag Appoints Winston Griffin as Chief Financial Officer to Support its Global Finance and Market Expansion Strategy". Freiburg/Breisgau. 2020-08-04
MYR GmbH. (8/4/20). "Press Release: MYR Pharmaceuticals Receives Conditional Marketing Authorization by the European Commission for Hepcludex". Bad Homburg. 2020-08-04
UCL Business. (8/3/20). "Press Release: UCL Technology Fund Announces First Close of £100m Fund 2". 2020-08-03
Valo Therapeutics Ltd.. (8/3/20). "Press Release: Valo Therapeutics Appoints Industry Veteran Paul G Higham as CEO". Oxford & Helsinki. 2020-08-03
NBE Therapeutics AG. (8/3/20). "Press Release: NBE-Therapeutics Appoints Bertrand Damour as Chief Executive Officer". Basel. 2020-08-03
Siemens Healthineers AG. (8/2/20). "Press Release: Siemens Healthineers Plans Acquisition of Varian". 2020-08-02
Immunic, Inc.. (8/2/20). "Press Release: Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis – Reports Results 2020 Q2". New York, NY. 2020-08-02
MorphoSys AG. (8/1/20). "Press Release: FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)". Planegg & Wilmington, DE. 2020-08-01
BioNTech SE. (7/31/20). "Press Release: Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate". New York, NY & Mainz. 2020-07-31
BaselArea.swiss. (7/31/20). "Press Release: Yokogawa Establishes Innovation Center in Allschwil". 2020-07-31
GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK in Advanced Discussions with European Union to Supply up to 300 Million Doses of COVID-19 Vaccine". London & Paris. 2020-07-31
GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 vaccine". London & Paris. 2020-07-31
BioNTech SE. (7/31/20). "Press Release: BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo (cemiplimab) Combination in Melanoma". Mainz. 2020-07-31
Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan. 2020-07-30
Vico Therapeutics B.V.. (7/29/20). "Press Release: Biotech Vico Therapeutics Raises $31 Million (€27 Million) in Series A Financing Round to Advance Therapies for Rare Central Nervous System Diseases". Leiden. 2020-07-29
Alentis Therapeutics AG. (7/29/20). "Press Release: Alentis Therapeutics Names Roberto Iacone CEO". Basel. 2020-07-29
DNA Script. (7/29/20). "Press Release: DNA Script Expands Series B to $89M". Paris & South San Francisco, CA. 2020-07-29
4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge. 2020-07-28
Abzena Ltd.. (7/28/20). "Press Release: Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners". Cambridge, Bristol, PA & San Diego, CA. 2020-07-28
Coulter Partners. (7/28/20). "Press Release: Coulter Partners Secures Chief Executive Officer for Optimapharm". 2020-07-28
ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven. 2020-07-28
Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. 2020-07-28
Polyphor Ltd.. (7/28/20). "Press Release: Polyphor Strengthens Financial Flexibility with CHF 19.3 million Equity-linked Financing". Allschwil. 2020-07-28
Enthera S.r.l.. (7/28/20). "Press Release: Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease". Milan. 2020-07-28
BioNTech SE. (7/27/20). "Press Release: BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares". Mainz. 2020-07-27
BioNTech SE. (7/27/20). "Press Release: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study". New York, NY & Mainz. 2020-07-27
iTeos Therapeutics Inc.. (7/23/20). "Press Release: iTeos Therapeutics Announces Pricing of Initial Public Offering". Cambridge, MA & Gosselies. 2020-07-23
Bayer AG. (7/22/20). "Press Release: Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures". Cambridge, MA & Berlin. 2020-07-22
BioNTech SE. (7/22/20). "Press Release: Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-22
BioNTech SE. (7/22/20). "Press Release: BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering". Mainz. 2020-07-22
Max Planck Institute for Biophysical Chemistry (MPI-BPI). (7/22/20). "Press Release: One of the World´s Three Most Powerful High-resolution 1.2 GHz NMR Spectrometers Comes to Göttingen". 2020-07-22
T3 Pharmaceuticals AG. (7/22/20). "Press Release: T3 Pharma Raises 25M CHF to Advance Bacterial Cancer Therapy through Clinic". Basel. 2020-07-22
BioNTech SE. (7/21/20). "Press Release: Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data". Mainz & New York, NY. 2020-07-21
Tubulis GmbH. (7/21/20). "Press Release: Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates". Munich. 2020-07-21
Citryll B.V.. (7/21/20). "Press Release: Industry Veterans Paul Peter Tak and Eric Meldrum Join Citryll’s Board". Oss. 2020-07-21
Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". 2020-07-21
CureVac AG. (7/21/20). "Press Release: CureVac Raises a Total of USD 640 Million in Private Financing Round". Tübingen. 2020-07-21
Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. 2020-07-21
BioNTech SE. (7/21/20). "Press Release: BioNTech Announces Proposed Public Offerings". Mainz. 2020-07-21
Apollo Therapeutics Fund. (7/21/20). "Press Release: UCLB and Apollo Therapeutics Secure First Out-licensing Deal to Deerfield, a Leading U.S. Healthcare Investment Firm". London & New York, NY. 2020-07-21
BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-20
Valneva S.E.. (7/20/20). "Press Release: Valneva Confirms Participation in UK Government COVID-19 Vaccine Response Program". Saint-Herblain. 2020-07-20
CureVac AG. (7/20/20). "Press Release: GSK and CureVac Announce Strategic mRNA Technology Collaboration". 2020-07-20
Zur Rose Group AG. (7/16/20). "Press Release: Zur Rose Group Acquires TeleClinic, Germany's Leading Telemedicine Provider". 2020-07-16
Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo. 2020-07-16
Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. 2020-07-15
Merck KGaA. (7/15/20). "Press Release: Merck Invests € 18 Million in New Life Science Laboratory in Switzerland". Darmstadt. 2020-07-15
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. 2020-07-15
Inflazome Ltd.. (7/14/20). "Press Release: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)". Dublin, Cambridge & Brisbane. 2020-07-14
Roche. (7/14/20). "Press Release: Roche Collaborates with Blueprint Medicines to Bring a New Treatment to People with RET-altered Cancers". Basel. 2020-07-14
MorphoSys AG. (7/14/20). "Press Release: MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis". Planegg. 2020-07-14
Macomics Ltd.. (7/14/20). "Press Release: Macomics, an Immuno-oncology Company, Secures £3.2 Million Seed Funding from Epidarex Capital & the Scottish Investment Bank". Edinburgh. 2020-07-14
iOnctura S.A.. (7/14/20). "Press Release: iOnctura Extends Series A to EUR 20.1m". Geneva. 2020-07-14
Illumina, Inc.. (7/14/20). "Press Release: Illumina Acquires Enancio’s Compression Software. Reduces Genomic Data Storage and Transfer Costs Associated with the Data Deluge". 2020-07-14
Reapplix A/S. (7/14/20). "Press Release: Reapplix Receives New Reimbursement Coding and Completes USD 22.6m Equity Financing to Drive US Commercialization". 2020-07-14
Miltenyi Biotec B.V. & Co. KG. (7/14/20). "Press Release: Miltenyi Biotec Offers Automated and Closed Adherent Cell Culture Solutions on CliniMACS Prodigy". Bergisch Gladbach. 2020-07-14
BioNTech SE. (7/13/20). "Press Release: Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2". New York, NY & Mainz. 2020-07-13
Merck KGaA. (7/13/20). "Press Release: Changes in Merck Executive Board. Belén Garijo appointed Vice Chairman of the Executive Board and Deputy CEO – Udit Batra Leaves". Darmstadt. 2020-07-13
Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam. 2020-07-13
Spirea Ltd.. (7/13/20). "Press Release: Spirea Completes Seed Funding Round to Develop the Next Generation of Antibody Drug Conjugate Therapeutics". Cambridge. 2020-07-13
Eir Ventures. (7/10/20). "Press Release: New Nordic Life Science Venture Fund, Eir Ventures, Launched to Leverage the Untapped Potential of Health Care Innovation". Stockholm & Copenhagen. 2020-07-10
Merck KGaA. (7/10/20). "Press Release: Merck Opens its Largest M Lab Collaboration Center in Shanghai". Darmstadt. 2020-07-10
Moderna, Inc.. (7/9/20). "Press Release: Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate". Cambridge, MA & Madrid. 2020-07-09
Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. 2020-07-09
Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen. 2020-07-09
Belgian Growth Fund. (7/9/20). "Press Release: Final Closing Belgian Growth Fund at 312 Million Euro". 2020-07-09
Kymera Therapeutics Inc.. (7/9/20). "Press Release: Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Advance Novel Protein Degrader Therapies to Patients". Cambridge, MA. 2020-07-09
Anergis S.A.. (7/9/20). "Press Release: Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy". Epalinges. 2020-07-09
VelosBio Inc.. (7/8/20). "Press Release: VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology". 2020-07-08
Kaiku Health. (7/8/20). "Press Release: Kaiku Health Expands Collaboration with Roche in Digital Patient Monitoring and Management". 2020-07-08
MLM Medical Labs GmbH. (7/8/20). "Press Release: MLM Medical Labs Expands to the US and Nominates Thomas Wollman as Member of the Board". Düsseldorf. 2020-07-08
VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. 2020-07-08
Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam. 2020-07-08
next pagenext page 1 2 3 ... 171 172 173  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top